Alvarez, Edgardo A.
HRN: 26-62-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/24/2025
01/30/2025
IV
43mg
OD
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes